Back to Results
First PageMeta Content
Angiotensin II receptor antagonists / Tetrazoles / Organochlorides / Novartis / Valsartan / Aliskiren / Antihypertensive drug / ACE inhibitor / Amlodipine / Chemistry / Organic chemistry / Amides


Document Date: 2011-12-20 11:43:38

Open Document

File Size: 116,79 KB

Share Result on Facebook

City

Basel / /

Company

Novartis International AG / Novartis Group / Novartis Pharmaceuticals / Novartis AG / Twitter / /

Continent

North America / /

Country

Switzerland / United States / /

Currency

USD / /

/

Event

FDA Phase / /

IndustryTerm

aliskiren combination products / over-the-counter and animal health products / healthcare / generic pharmaceuticals / study site / diagnostic tools / healthcare solutions / treatment of hypertension / /

MedicalCondition

hypotension / hyperkalemia / non-fatal stroke / hypertension / diabetes / high blood pressure / /

Organization

US Securities and Exchange Commission / Data Monitoring Committee / European Union / /

Person

Richard Jarvis Jill Pozarek Edwin Valeriano / David Epstein / Susanne Schaffert Pierre-Michel / John Taylor / Thomas Hungerbuehler Isabella Zinck / /

/

Position

Division Head / physician / /

Product

valsartan / Tekturna HCT / Tekturna / hydrochlorothiazide / Rasilez / Rasilez®/ Tekturna / Rasilez®/Tekturna® / /

URL

http /

SocialTag